Mesenchymal Stem Cells Market Overview
Mesenchymal stem cells found in connective tissue and organ stoma, especially this cells found in bone marrow tissue, Mesenchymal cells are derived from mesoderm. Mesenchymal stem cells are stromal cells that have the ability to self-renew and this cell is also exhibit multiline age differentiation. Mesenchymal can be isolated from different type of tissues such as umbilical cord, endometrial polyps, menstrual blood, bone marrow, adipose tissue etc. mesenchymal stem cells is used in anti-inflammatory treatment, tissue regeneration, and best versus host response, autoimmune diseases and gene transfection. Nowadays, this cell is commonly used in mesenchymal stem cell sorting methods including immunomagnetic bead sorting, whole bone marrow culture, and tissue digestion. Rising road accidents and deaths due to accidents worldwide are another factor driving the market growth during the forecast period. Most road accidents result in severe or traumatic injuries that require surgery for treatment In addition, increasing per capita disposable income among people worldwide is leading to better wound healing and increasing demand for mature stem cells, such as mesenchymal stem cells. Global Mesenchymal Stem Cells Market size accounted for US$ 2.8 billion in 2022 and is estimated to be US$ 9.17 billion by 2032 and is anticipated to register a CAGR of 12.8%.
Mesenchymal Stem Cells Market Dynamics
Increasing number of clinical trials.
Mesenchymal stem cells which acquire characteristics like self-renewal and differentiation potential, mesenchymal stem cells is isolated from a different type of tissue sources contain in bone marrow, peripheral blood, umbilical , adipose tissue, and lung, dental pulp, skeletal muscle, umbilical cord blood. In particular, instead of bone marrow-derived MSCs or adipose tissue-derived MSCs, MSCs have been proposed as a potential source of MSCs for cell therapy for bone diseases such as osteoporosis. Mesenchymal stem cells market growth is increases Because of the increased incidence of cancer, neurological disorders, and cardiac ischemia, diabetes and bone and cartilage diseases and increasing number of clinical trials.
Increased research and development
Sources of mesenchymal stem cells are used in clinical therapies. Recent developments in the field of reproductive medicine due to mesenchymal stem cell-based research are expected to drive the market. For instance, In August 2022, Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis, Osteosarcoma is the most common malignant bone tumor that occurs mainly in children and adolescents. The standard treatments consist of preoperative neoadjuvant chemotherapy, surgical resection of osteosarcoma tissue, and postoperative chemotherapy with doxorubicin, cisplatin, and ifosfamide.
In July 2022, Mesenchymal stem cells exert renoprotection via extracellular vesicle-mediated modulation of M2 macrophages and spleen-kidney network, mesenchymal stem cells is clinically applied to different type of diseases, especially those that are difficult to treat with currently existing immunosuppressive drugs. Clinical trial is used to adipose-derived for patients with refractory IgA nephritis.
Restraints:
High cost of treatment is expected to restrain market growth during the forecast period. Articular cartilage is a unique tissue because of its ability to withstand repetitive compressive stress throughout an individual's life. However, its major limitation is its inability to heal even minor wounds.
Mesenchymal Stem Cells Market Segmentation
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
The Global Mesenchymal Stem Cells Market is segmented based on Treatment Type, Product, Source of Isolation, Application and Region.
On the basis of Treatment Type, the Global Mesenchymal Stem Cells Market is segmented into Autologous, Allogeneic. On the basis of Product, Global Mesenchymal Stem Cells Market is segmented into Cell Sourcing, Culture & Cryopreservation, Others. On the basis of Isolation, Global Mesenchymal Stem Cells Market is segmented into Bone Marrow, Cord Blood, Peripheral Blood, Lungs, Others. On the basis of Application, Global Mesenchymal Stem Cells Market is segmented into Disease modeling, Drug development and discovery, Stem cell banking, Tissue engineering, Toxicology studies) and Geography.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
On region the Global Mesenchymal Stem Cells Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In Asia Pacific region, the region expected to create strong competitors in this space. Lack of financial support for hard surgical procedures and finite access to healthcare in the Asia Pacific region have led to raised adoption of stem cell therapies. Big population size and low working cost are attributive to the acceptation of Mesenchyamal stem cells in this region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022– 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Type - Autologous, Allogeneic By Product – Cell Sourcing, Culture & Cryopreservation, Others By Isolation - Bone Marrow, Cord Blood, Peripheral Blood, Lungs, Others By Application– Disease modeling, Drug development and discovery, Stem cell banking, Tissue engineering, Toxicology studies and Geography.
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Mesenchymal Stem Cells Market report based on test, application, and Region:
Global Mesenchymal Stem Cells Market, By Type:
- Autologous
- Allogeneic
Global Mesenchymal Stem Cells Market, By Product:
- Cell Sourcing
- Culture & Cryopreservation
- Others
Global Mesenchymal Stem Cells Market, By Isolation:
- Bone Marrow
- Cord Blood
- Peripheral Blood
- Lungs
- Others
Global Mesenchymal Stem Cells Market, By Application:
- Disease modeling
- Drug development and discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies and Geography
Global Mesenchymal Stem Cells Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Mesenchymal Stem Cells Market Key Players
The key players operating the Global Mesenchymal Stem Cells Market includes Astellas Pharma Inc., Axol Biosciences Ltd., Brainstorm Cell Therapeutics Inc., Cell Applications Inc., Celprogen Inc., Cyagen Biosciences Inc., Genlantis Inc., Lonza Group AG, and Merck KGaA, Pluristem Therapeutics Inc.
In August 2022, Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis, The mouse bone marrow cells (BM-MSCs) with stable transfection of GFP were obtained from Cyagen Biosciences Inc., (Guangzhou, China), the quality inspection report was done by the company.
Mesenchymal Stem Cells Market Company Profile
- Astellas Pharma Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Axol Biosciences Ltd.
- Brainstorm Cell Therapeutics Inc.
- Cell Applications Inc.
- Celprogen Inc.
- Cyagen Biosciences Inc.
- Genlantis Inc.
- Lonza Group AG
- Merck KGaA
- Pluristem Therapeutics Inc.
“*” marked represents similar segmentation in other categories in the respective section
Mesenchymal Stem Cells Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Treatment
- Market Snippet, By Product
- Market Snippet, By Source of Isolation
- Market Snippet, By Application
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Mesenchymal Stem Cells Market, By Treatment
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Autologous
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Allogeneic
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Mesenchymal Stem Cells Market, By Product, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Cells Sourcing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Culture & Cryopreservation
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Mesenchymal Stem Cells Market, By Source of Isolation, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Bone Marrow
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cord Blood
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Peripheral Blood
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Lungs
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Mesenchymal Stem Cells Market, By Application, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Disease modeling
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Drug development and discovery
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Stem cell banking
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Tissue engineering
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Toxicology studies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Geography
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Mesenchymal Stem Cells Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Treatment, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Source of Isolation, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Treatment, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Source of Isolation, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Treatment, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Source of Isolation, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Treatment, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Source of Isolation, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Treatment, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Product, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Source of Isolation, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Astellas Pharma Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Axol Biosciences Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Brainstorm Cell Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cell Applications Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Celprogen Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cyagen Biosciences Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Genlantis Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lonza Group AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pluristem Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Mesenchymal Stem Cells Market is segmented based on Treatment Type, Product, Source of Isolation, Application and Region.
Mesenchymal stem cells market growth is increases Because of the increased incidence of cancer, neurological disorders, and cardiac ischemia, diabetes and bone and cartilage diseases and increasing number of clinical trials.
In Asia Pacific region, the region expected to create strong competitors in this space. Lack of financial support for hard surgical procedures and finite access to healthcare in the Asia Pacific region have led to raised adoption of stem cell therapies. Big population size and low working cost are attributive to the acceptation of Mesenchyamal stem cells in this region.
The key players operating the Mesenchymal Stem Cells Market includes Astellas Pharma Inc., Axol Biosciences Ltd., Brainstorm Cell Therapeutics Inc., Cell Applications Inc., Celprogen Inc., Cyagen Biosciences Inc., Genlantis Inc., Lonza Group AG, and Merck KGaA, Pluristem Therapeutics Inc.